Role of catheter ablation in the treatment of scar-related ventricular tachycardia

The article focuses on the role of catheter ablation in the treatment of ventricular tachycardias associated with myocardial fibrosis. The optimal treatment strategy has been determined. Particular attention is given to the implantation of cardioverter-defibrillators used for the primary and secondary prevention of sudden cardiac death. Poor quality of life and other main problems generally caused by the Abstract                electropulse therapy are described. The role of catheter radiofrequency ablation has been determined as the main method for treating patients experiencing electrical storm or psychological discomfort due to frequent painful defibrillations. In addition, the article covers issues related to the technical and tactical difficulties of performing catheter ablation, and studies the results of recent large-scale clinical research concerning the analysis of its efficiency and safety, including comparison with other treatment strategies.

1. de Bakker JM, van Capelle FJ, Janse MJ, Wilde AA, Coronel R, Becker AE, Dingemans KP, van Hemel NM, Hauer RN. Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation. 1988 Mar;77(3):589-606.

2. de Bakker JM, van Capelle FJ, Janse MJ, Tasseron S, Vermeulen JT, de Jonge N, Lahpor JR. Slow conduction in the infarcted human heart. 'Zigzag' course of activation. Circulation. 1993 Sep;88(3):915-26.

3. Kong MH, Fonarow GC, Peterson ED, Curtis AB, Hernandez AF, Sanders GD, Thomas KL, Hayes Dl, Al-Khatib SM. Systematic review of the incidence of sudden cardiac death in the United States. J Am Coll Cardiol. 2011;57(7):794-801. doi: 10.1016/j.jacc.2010.09.064.

4. Kesteloot H, Sans S, Kromhout D. Dynamics of cardiovascular and all-cause mortality in Western and Eastern Europe between 1970 and 2000. Eur Heart J. 2006;27(1):107-113. doi: 10.1093/eurheartj/ehi511.

5. Nichol G, Thomas E, Callaway CW, Hedges J, Powell JL, Aufderheide TP, Rea T, Lowe R, Brown T, Dreyer J, Davis D, Idris A, Stiell I; Resuscitation Outcomes Consortium Investigators. Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA. 2008 Sep 24;300(12):1423-31. doi: 10.1001/jama.300.12.1423.

6. Maqsood MH, Rubab K. The Role of the Cardioversion Defibrillator in Post Myocardial Infarction Sudden Cardiac Death: A Systematic Review of Clinical Trials and Observational Studies. Cureus. 2019;11(3):e4314. doi: 10.7759/cureus.4314.

7. Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott pM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck K-H, Hernandez-Madrid A, Nikolaou N, Norekval TM, Spaulding C, Van Veldhuisen DJ, ESC Scientific Document Group. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Eur Heart J. 2015;36(41):2793-2867. doi/10.1093/eurheartj/ehv316

8. Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Granger CB, Hammill SC, Hlatky MA, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Circulation. 2018 Sep 25;138(13):e272-e391. doi: 10.1161/CIR.0000000000000549.

9. Abdullaev A.A., Aver'yanov A.V., Arutyunov A.G., Boldueva S.A., Borisov I.A., Babokin V.E., Bacigov H.A., Butaev T.D, Gizatulina T.P., Grineva E.N., Gromyko G.V., Dzahoev M.E, Dorofeeva N.P., Drapkina O.M., Duplyakov D.V., Egorov D.F., Doshchicin V.L., zHelyakov E.G., Zabozlaev F.G., Zaruckij A.A, Zatejshchikov D.A., Zotova I.V., Il'nickij A.N., Kanorskij S.G., Kalinkin A.L., Karoli I.A., Karonova T.L., Kondratova N.V., Knigin A.V., Koval'chuk V.V. Koziolova N.A., Komolyatova VI., Kosmacheva ED., Kocharyan A.A., Kuznecov V.A., Kuzovlev A.N., Lapshina I.V, Linchak R.M., Lyshova O.V., Mamchur S.E. i dr. Nacional'nye rekomendacii po opredeleniyu riska i profilaktike vnezapnoj serdechnoj smerti. 2-e izd. Moscow: ID «Medpraktika-M»; 2018. 247 p. (In Russian)

10. Revishvili A.SH., Neminushchij N.M., Batalov R.E., Blagova O.V, Golicyn S.P., Davtyan K.V, Didenko M.V., Dumpis YA.YU., Zenin S.A., Ivanickij E.A., Il'darova R.A., Kandinskij M.L., Komolyatova VN., Kravcova L.A., Krivolapov S.N., Kuzovlev A.N., Kupcov VV, Lebedev D.S., Lebedeva VK., Linchak R.M., Lomidze N.N., Makarov L.M., Mamchur S.E., Mironov N.YU., Medvedev M.M., Mihajlov E.N., Molodyh S.V, Nedbajkin A.M., Nesterenko L.YU., Romanov A.B., Rzaev F.G., Solohin YU.A., Tatar-skij R.B., Harlap M.S., CHapurnyh A.V, SHkol'nikova M.A., SHlevkov N.B., SHubik YU.V, YAshin S.M. Vserossijskie klinicheskie rekomendacii po kontrolyu nad riskom vnezapnoj ostanovki serdca i vnezapnoj serdechnoj smerti, profilaktike i okaza-niyu pervoj pomoshchi. M.: GEOTAR-Media, 2018. - 256 s.

11. Abdulaev AA, Averyanov AV, Arutyunov AG, Boldueva SA, Borisov IA, Babokin VE, Batsygov HA et al. Russian guidelines for sudden cardiac death risk assessment and prevention (second edition) - 2018. Journal of the Grodno State Medical University 2019;17(3): 247-277. doi: 10:25298/2221-8785-2019-17-3-247-277.

12. Markman TM, Nazarian S, Treatment of ventricular arrhythmias: What’s New? Trends Cardiovasc Med. 2019 Jul;29(5):249-261. doi: 10.1016/j.tcm.2018.09.014.

13. Moss AJ. MADIT-I and MADIT-II. J Cardiovasc Electrophysiol. 2003;14(9 Suppl):S96-8.

14. Rogers PA, Morin DP. MADIT-CRT and his many sons. Trends Cardiovasc Med. 2016;26(2):147-9. doi: 10.1016/j.tcm.2015.05.011.

15. The AVID Investigators. Causes of death in the antiarrhythmics versus implantable defibrillators (AVID) trial. JACC 1999;34(5): 1552-1559. doi: 10.1016/S0735-1097(99)00376-9.

16. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005 Jan 20;352(3):225-37. doi: 10.1056/NEJMoa043399.

17. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White bG, DeVries DW, Feldman AM; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004 May 20;350(21):2140-50. doi: 10.1056/NEJMoa032423.

18. Rogers PA, Morin DP. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005 Jan 20;352(3):225-37. doi: 10.1056/NEJMoa043399.

19. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH; Defibrillators in NonIschemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004 May 20;350(21):2151-8. doi: 10.1056/NEJMoa033088.

20. SaxonLA, Hayes DL, GilliamFR, HeidenreichPA, Day J, Seth M, Meyer TE, Jones PW, Boehmer JP. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study. Circulation. 2010 Dec 7;122(23):2359-67. doi: 10.1161/CIRCULATIONAHA.110.960633.

21. Schwab JO, Bonnemeier H, Kleemann T, Brachmann J, Fischer S, Birkenhauer F, Eberhardt F. Reduction of inappropriate ICD therapies in patients with primary prevention of sudden cardiac death: DECREASE study. Clin Res Cardiol. 2015 Dec;104(12):1021-32. doi: 10.1007/s00392-015-0870-z.

22. Knackstedt C, Arndt M, Mischke K, Marx N, Nieman F, Kunert HJ, Schauerte P, Norra C. Depression, psychological distress, and quality of life in patients with cardioverter defibrillator with or without cardiac resynchronization therapy. Heart Vessels. 2014 May;29(3)G64-74. doi: 10.1007/s00380-013-0372-8.

23. Arenal A, Hernandez J, Calvo D, Ceballos C, Atea L, Datino T, Atienza F, Gonzalez-Torrecilla E, E^delman G, Miracle A, Avila P, Bermejo J, Fernandez-Aviles F. Safety, long-term results, and predictors of recurrence after complete endocardial ventricular tachycardia substrate ablation in patients with previous myocardial infarction. Am J Cardiol. 2013 Feb 15;111(4):499-505. doi: 10.1016/j.amjcard.2012.10.031.

24. Proclemer A, Dagres N, Marinskis G, Pison L, Lip GY, Blomstrom-Lundqvist C; Scientific Initiative Committee, European Heart Rhythm Association. Current practice in Europe: how do we manage patients with ventricular tachycardia? European Heart Rhythm Association survey. Europace. 2013 Feb;15(2):167-9. doi: 10.1093/europace/eus436.

25. Singer I, editors. Interventional Electrophysiolog. 2nd ed. Lippincott: Williams & Wilkins; 2001. 858 p.

26. SKC Huang, DJ Wilber, editors. Radiofrequency Catheter Ablation of Cardiac Basic Concepts and Clinical Applications. 2nd ed. Futura Publishing; 2000. 868 p.

27. Namboodiri N. Electroanatomic contact mapping: how to use optimally to recognise the arrhythmia mechanism? Indian Pacing Electrophysiol J. 2010 Jan 7;10(1):1-7.

28. Casella M, Perna F, Dello Russo A, Pelargonio G, Bartoletti S, Ricco A, Sanna T, Pieroni M, Forleo G, Pappalardo A, Di Biase L, Natale L, Bellocci F, Zecchi P, Natale A, Tondo C. Right ventricular substrate mapping using the Ensite Navx system: Accuracy of high-density voltage map obtained by automatic point acquisition during geometry reconstruction. Heart Rhythm. 2009 Nov;6(11):1598-605. doi: 10.1016/j.hrthm.2009.07.040.

29. Morady F, Harvey M, Kalbfleisch SJ, el-Atassi R, Calkins H, Langberg JJ. Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease. Circulation. 1993 Feb;87(2):363-72. doi: 10.1161/01.cir.87.2.363.

30. Sacher F, Lim HS, Derval N, Denis A, Berte B, Yamashita S, Hocini M, Haissaguerre M, Jais P. Substrate mapping and ablation for ventricular tachycardia: the LAVA approach. J Cardiovasc Electrophysiol. 2015 Apr;26(4):464-471. doi: 10.1111/jce.12565.

31. Scanavacca M. Epicardial ablation for ventricular tachycardia in chronic Chagas heart disease. Arq Bras Cardiol. 2014;102(6):524-528. doi:10.5935/abc.20140082.

32. Mamchur S.E., Khomenko E.A., Bokhan N.S., Mamchur I.N. Ultrasound mapping for ablation of postinfarction ventricular re-entry tachycardia: first experience in Russia. Vestnik aritmologii 2013;74:35-39.

33. Mamchur S.E., Homenko E.A., Bohan N.S., Gorbunova E.V Ul'trazvukovoe kartirova-nie i radiochastotnaya ablaciya elektricheskogo shtorma u kandidata na transplantaciyu serdca. Vestnik aritmologii 2014;78:66-70.

34. Kuck KH, Schaumann A, Eckardt L, Willems S, Ventura R, Delacretaz E, Pitschner HF, Kautzner J, Schumacher B, Hansen PS; VTACH study group. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicenter randomised controlled trial. Lancet. 2010 Jan 2;375(9708):31-40. doi: 10.1016/S0140-6736(09)61755-4.

35. Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, Kralovec S, Sediva L, Ruskin JN, Josephson ME. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007 Dec 27;357(26):2657-65. doi: 10.1056/NEJMoa065457.

36. Al-Khatib SM, Daubert JP, Anstrom KJ, Daoud EG, Gonzalez M, Saba S, Jackson KP, Reece T, Gu J, Pokorney SD, Granger CB, Hess PL, Mark DB, Stevenson wG. Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial. J Cardiovasc Electrophysiol. 2015 Feb;26(2):151-7. doi: 10.1111/jce.12567.

37. Sapp JL, Wells GA, Parkash R, Stevenson WG, Blier L, Sarrazin JF, Thibault B, Rivard L, Gula L, Leong-Sit P, Essebag V, Nery PB, Tung SK, Raymond JM, Sterns LD, Veenhuyzen GD, Healey JS, Redfearn D, Roux JF, Tang AS. Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs. N Engl J Med. 2016 Jul 14;375(2): 111-21. doi: 10.1056/NEJMoa1513614.

38. Arenal A, Glez-Torrecilla E, Ortiz M, Villacastm J, Fdez-Portales J, Sousa E, del Castillo S, Perez de Isla L, Jimenez J, Almendral J. Ablation of electrograms with an isolated, delayed component as treatment of unmappable monomorphic ventricular tachycardias in patients with structural heart disease. J Am Coll Cardiol. 2003;41(1):81-92.

39. Dinov B, Schratter A, Schirripa V, Fiedler L, Bollmann A, Rolf S, Sommer P, Hindricks G, Arya A. Procedural Outcomes and Survival After Catheter Ablation of Ventricular Tachycardia in Relation to Electroanatomical Substrate in Patients With Nonischemic-Dilated Cardiomyopathy: The Role of Unipolar Voltage Mapping. J Cardiovasc Electrophysiol. 2015 Sep;26(9):985-993. doi: 10.1111/jce.12715.

40. Souissi Z, Boule S, Hermida JS, Doucy A, Mabo P, Pavin D, Anselme F, Auquier N, Ninni S, Coisne A, Brigadeau F, Deken-Delannoy V, Klug D, Lacroix D. Catheter ablation reduces ventricular tachycardia burden in patients with arrhythmogenic right ventricular cardiomyopathy: insights from a north-western French multicentre registry. Europace. 2018 Feb 1;20(2):362-369. doi: 10.1093/europace/euw332.

41. Pandian J, Kaur D, Yalagudri S, Devidutta S, Sundar G, Chennapragada S, Narasimhan C. Safety and efficacy of epicardial approach to catheter ablation of ventricular tachycardia - An institutional experience. Indian Heart J. 2017 Mar - Apr;69(2):170-175. doi: 10.1016/j.ihj.2016.10.010.

42. Stevenson WG, Wilber DJ, Natale A, Jackman WM, Marchlinski FE, Talbert T, Gonzalez MD, Worley SJ, Daoud EG, Hwang C, Schuger C, Bump TE, Jazayeri M, Tomassoni GF, Kopelman HA, Soejima K, Nakagawa H; Multicenter Thermocool VT Ablation Trial Investigators. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial. Circulation. 2008 Dec 16;118(25): 2773 -82. doi: 10.1161/CIRCULAnONAHA.108.788604.

43. Marchlinski FE, Haffaj ee CI, Beshai JF, IDickfeld TL, Gonzalez MD, Hsia HH, Schuger CD, Beckman KJ, Bogun FM, Pollak SJ, Bhandari AK. Long-Term Success of Irrigated Radiofrequency Catheter Ablation of Sustained Ventricular Tachycardia: PostApproval THERMOCOOL VT Trial. J Am Coll Cardiol. 2016 Feb 16;67(6):674-683. doi: 10.1016/jjacc.2015.11.041.

44. Pisani C, Hardy C, Lara S, Chokr M, Bellotti H, Hachul D, Darrieux F, Sosa E, Scanavacca M. Abstract 16621: Clinical Results of Scar Related Ventricular Tachycardia Ablation Performed in a South America School Hospital. Circulation. 2015;132, suppl. 3: A16621.